3Cole N, Gibson BE. High-dose c ytosine arabinoside in the treatment ofacute myeloid leukemia. Blood Rev, 1997;11(1):39.
4Mayer RI, Davis RB, Schiffer CA, et al. Intensive postremission chemotherapy in adults with acute myeloid leukaemia. Cancer and Leukemia Group B. N Engl J Med,1994;331:896-903.
5Alexandra B, Maria P, Friedrich W, et al. High dose intermittent ARA-C(HiDAC) for consolidation of patients with de novo AML: a single center experience. Leukemia Research)2005 ;29:609-615.
6Cole N, Gibson BE. High-dose cytosine arabinoside in the treatment of acute myeloid leukemia. Blood Rev, 1997;11 (1) :39.
7Cheson BD, Cassileth PA, Head DR, et al. Report of the National Cancer Institute sponsored workshop on definitions o5 diagnosis and response in acute myeloid leukemia. J Clin Oncol, 1990 ;8:813-819.
8Buchner T, Hiddemann W, Berdel W, et al. Acute myeloid leukemia:treatment over 60. Rev Clin ExtpHematol,2002:6:46-59.
9Sperr WR, Hauswirth AW, Wimazal F, et al. Treatment concepts for elderly patients with acute myeloid leukemia. Wien Klin Wochenschr, 2003 ; 115:505-114.
10Herzig RH, Wolff SN, Lazarus HM, et al. High-dose cytosine arabinoside therapy for refractory leukemia. Blood, 1983 ;62:361-369.
